[Therapeutic progress: 1977].
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D001073:Aprindine / Q000627:therapeutic use; D002635:Chenodeoxycholic Acid / Q000627:therapeutic use*; D002927:Cimetidine / Q000627:therapeutic use*; D005100:Expectorants / Q000627:therapeutic use; D006146:Guanidines / Q000627:therapeutic use*; D006801:Humans; D000960:Hypolipidemic Agents / Q000627:therapeutic use; D007328:Insulin / Q000627:therapeutic use; D007978:Levamisole / Q000627:therapeutic use*; D012853:Sisomicin / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D005100:Expectorants; D006146:Guanidines; D000960:Hypolipidemic Agents; D007328:Insulin; D002635:Chenodeoxycholic Acid; D007978:Levamisole; D001073:Aprindine; D002927:Cimetidine; D012853:Sisomicin
Actualités thérapeutiques 1977.